Document:

Exhibit 10.6

 

INDEMNITY AGREEMENT

 

This Indemnity Agreement
(the “Agreement”), dated as of June ___, 2020, is entered into by and among Olivia Ventures, Inc., a
Delaware corporation (the “Parent”), Compass Therapeutics LLC, a Delaware limited liability company (“Compass”
and together with the Parent, the “Companies”), and the undersigned Indemnitee (the “Indemnitee”)

 

W I T N E S S E T H:

 

WHEREAS, Indemnitee
is a director on the board of directors of the Parent (the “Board of Directors”) and/or an officer of the Parent
and in such capacity(ies) is performing valuable services for the Parent; and

 

WHEREAS, the Parent,
Compass Acquisition LLC, a wholly-owned subsidiary of the Parent (the “Merger Sub”), and Compass plan to enter
into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), pursuant to which the Merger
Sub shall merge with and into Compass, with Compass remaining as the surviving entity and a wholly-owned operating subsidiary of
the Parent (the “Merger”); and

 

WHEREAS, it is intended
that Indemnitee shall be paid promptly by the Companies all amounts necessary to effectuate in full the indemnity provided herein;

 

NOW, THEREFORE, in
consideration of the premises and the covenants in this Agreement, and of Indemnitee and the Companies intending to be legally
bound hereby, the parties hereto agree as follows:

 

1. Indemnification.
Subject to the limitations set forth herein and in Section 6 hereof, the Companies hereby agree to indemnify
Indemnitee as follows:

 

The Companies shall,
from and after the Effective Time, with respect to any Proceeding (as hereinafter defined), indemnify Indemnitee to the fullest
extent permitted by (in the case of the Parent) Section 145 of the General Corporation Law of the State of Delaware (the “DGCL”)
and the certificate of incorporation and by-laws of the Parent (the “Certificate of Incorporation”) or (in the
case of Compass) Section 18-108 of the Limited Liability Company Act of the State of Delaware (the “DLLCA”)
and the certificate of formation and limited liability company operating agreement of the Company in effect on the date hereof
or as such law or constitutive document may from time to time be amended (but, in the case of any such amendment, only to the extent
such amendment permits the relevant Company to provide broader indemnification rights than applicable law or constitutive document
permitted the applicable Company to provide before such amendment). Notwithstanding the foregoing, the Companies shall not be required
to indemnify Indemnitee for acts or omissions of Indemnitee constituting fraud, bad faith, gross negligence or intentional misconduct.
The right to indemnification conferred herein and in the constitutive documents of the Companies shall be presumed to have been
relied upon by Indemnitee in serving the Parent and shall be enforceable as a contract right. Without in any way diminishing the
scope of the indemnification provided by this Section 2, the Companies will, from and after the Effective Time,
indemnify Indemnitee against Expenses (as hereinafter defined) and Liabilities (as hereinafter defined) actually and reasonably
incurred by Indemnitee or on their behalves in connection with the investigation, defense, settlement or appeal of such Proceeding.
In addition to, and not as a limitation of, the foregoing, the rights of indemnification of Indemnitee provided under this Agreement
shall include those rights set forth in Section 8 below. Notwithstanding the foregoing, from and after the
Effective Time, the Companies shall be required to indemnify Indemnitee in connection with a Proceeding commenced by Indemnitee
(other than a Proceeding commenced by Indemnitee to enforce Indemnitee’s rights under this Agreement) only if the commencement
of such Proceeding was authorized by the Board of Directors following the Effective Time. Notwithstanding anything to the contrary
contained herein, the Parent shall have no obligation to indemnify the Indemnitee to the extent such indemnification would not
be permitted under Section 145 of the DGCL or the Parent’s certificate of incorporation in effect on the date hereof.

 

    

     

    

 

2. Presumptions
and Effect of Certain Proceedings. Upon making a request for indemnification, Indemnitee shall be presumed to be entitled to
indemnification under this Agreement and the Companies shall have the burden of proof to overcome that presumption in reaching
any contrary determination. The termination of any Proceeding by judgment, order, settlement, arbitration award or conviction,
or upon a plea of nolo contendere or its equivalent, shall not affect this presumption or, except as determined by a judgment or
other final adjudication adverse to Indemnitee, establish a presumption with regard to any factual matter relevant to determining
Indemnitee’s rights to indemnification hereunder.

 

3. Advancement
of Expenses. To the extent not prohibited by law, from and after the Effective Time, the Companies shall advance the Expenses
or Liabilities incurred by Indemnitee in connection with any Proceeding, and such advancement shall be made within thirty (30) calendar
days after the receipt by the Companies of a statement or statements requesting such advances (which shall include invoices received
by Indemnitee in connection with such Expenses or Liabilities but, in the case of invoices in connection with legal services, any
references to legal work performed or to expenditures made that would cause Indemnitee to waive any privilege accorded by applicable
law shall not be included with the invoice) and upon request of the Companies, an undertaking to repay the advancement of Expenses
or Liabilities if and to the extent that it is ultimately determined by a court of competent jurisdiction in a final judgment,
not subject to appeal, that Indemnitee is not entitled to be indemnified by the Companies. Advances shall be unsecured, interest
free and without regard to Indemnitee’s ability to repay the expenses. Advances shall include any and all Expenses and/or
Liabilities actually and reasonably incurred by Indemnitee pursuing an action to enforce Indemnitee’s right to indemnification
under this Agreement, or otherwise and this right of advancement, including Expenses and/or Liabilities incurred preparing and
forwarding statements to the Company to support the advances claimed. Indemnitee acknowledges that the execution and delivery of
this Agreement shall constitute an undertaking providing that Indemnitee shall, to the fullest extent required by law, repay the
advance if and to the extent that it is ultimately determined by a court of competent jurisdiction in a final judgment, not subject
to appeal, that Indemnitee is not entitled to be indemnified by the Company. The right to advances under this Section shall continue
until final disposition of any proceeding, including any appeal therein. This Section 4 shall not apply to
any claim made by Indemnitee for which indemnity is excluded pursuant to Section 15(d)(ii).

 

    2

     

    

 

4. Procedure
for Determination of Entitlement to Indemnification.

 

(a) Whenever
Indemnitee believes that Indemnitee is entitled to indemnification pursuant to this Agreement, Indemnitee shall submit a written
request for indemnification or advancement of expenses to the Companies. Any request for indemnification or advancement of expenses
shall include sufficient documentation or information reasonably available to Indemnitee for the determination of entitlement to
indemnification or advancement of expenses. In any event, Indemnitee shall submit Indemnitee’s claim for indemnification
or advancement of expenses within a reasonable time, not to exceed sixty calendar (60) days after any judgment, order, settlement,
dismissal, arbitration award, conviction, acceptance of a plea of nolo contendere or its equivalent, or final termination, whichever
is the later date for which Indemnitee requests indemnification.

 

(b) Independent
Legal Counsel (as hereinafter defined) shall determine whether Indemnitee is entitled to indemnification or advancement of expenses.
Determination of Indemnitee’s entitlement to indemnification or advancement of expenses shall be made not later than ninety
calendar (90) days after the Companies’ receipt of Indemnitee’s written request for such indemnification or advancement
of expenses, provided that any request for indemnification or advancement of expenses for Liabilities, other than amounts paid
in settlement, shall have been made after a determination thereof in a Proceeding.

 

5. Specific
Limitations on Indemnification. Notwithstanding anything in this Agreement to the contrary, the Companies shall not be obligated
under this Agreement to make any indemnity or payment to Indemnitee in connection with any claim against Indemnitee:

 

(a) to
the extent that payment is actually made to Indemnitee under any insurance policy, contract, agreement or otherwise or is made
to Indemnitee by either of the Companies or affiliates otherwise than pursuant to this Agreement. Notwithstanding the availability
of such insurance, Indemnitee also may claim indemnification from the Companies pursuant to this Agreement by assigning to the
Companies any claims under such insurance to the extent Indemnitee is paid by the Companies;

 

(b) for
Liabilities in connection with Proceedings settled without the Companies’ consent, which consent, however, shall not be unreasonably
withheld;

 

(c) in
no event shall the Companies be liable to pay the fees and disbursements of more than one counsel in any single Proceeding except
to the extent that, in the opinion of counsel of the Indemnitee, the Indemnitee has conflicting interests in the outcome of such
Proceeding;

 

(d) to
the extent it would be otherwise prohibited by law, if so established by a judgment or other final adjudication adverse to Indemnitee;

 

(e) for
an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Companies within
the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory
law or common law;

 

(f) in
connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of
any Proceeding) initiated by Indemnitee against the Companies or their directors, officers, employees or other indemnitees, unless
(i) the commencement of such Proceeding was authorized by the Board of Directors (or any part of any Proceeding) prior to
its initiation and following the Effective Time, or (ii) the Company provides the indemnification, in its sole discretion,
pursuant to the powers vested in the Company under applicable law; or

 

(g) for
any reimbursement of the Companies by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits
realized by Indemnitee from the sale of securities of the Companies, as required in each case under the Securities Exchange Act
of 1934, as amended (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304
of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Companies of profits
arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act), if
Indemnitee is held liable therefor.

 

    3

     

    

 

6. Fees
and Expenses of Independent Legal Counsel. The Companies agree to pay the reasonable fees and expenses of Independent Legal
Counsel and to fully indemnify such Independent Legal Counsel against any and all reasonable expenses and losses incurred by any
of them arising out of or relating to this Agreement or their engagement pursuant hereto.

 

7. Remedies
of Indemnitee.

 

(a) In
the event that (i) a determination pursuant to Section 5 hereof is made that Indemnitee is not entitled
to indemnification, (ii) payment has not been timely made following a determination of entitlement to indemnification pursuant
to this Agreement, (iii) the person or persons empowered to make a determination pursuant to Section 5 hereof
shall have failed to make the requested determination within ninety calendar (90) days after the Companies’ receipt
of Indemnitee’s written request for such indemnification or advancement of expenses, or (iv) Indemnitee otherwise seeks
enforcement of this Agreement, Indemnitee shall be entitled to a final adjudication in a court of competent jurisdiction in the
State of Delaware of the remedy sought.

 

(b) If
a determination that Indemnitee is entitled to indemnification has been made pursuant to Section 5 hereof,
or is deemed to have been made pursuant to Section 5 hereof or otherwise pursuant to the terms of this Agreement,
the Companies shall be bound by such determination in the absence of a misrepresentation or omission of a material fact by Indemnitee
in connection with such determination.

 

(c) The
Companies shall be precluded from asserting that the procedures and presumptions of this Agreement are not valid, binding and enforceable.
The Companies shall stipulate in any such court or before any such arbitrator that the Companies are bound by all the provisions
of this Agreement and are precluded from making any assertion to the contrary.

 

(d) Expenses
reasonably incurred by Indemnitee in connection with Indemnitee’s request for indemnification under, seeking enforcement
of or to recover damages for breach of this Agreement shall be borne by the Companies when and as incurred by Indemnitee, to the
extent it is determined that Indemnitee is entitled to indemnification hereunder.

 

    4

     

    

 

8. Contribution.
To the fullest extent permissible under applicable law, in the event the Companies are obligated to indemnify Indemnitee under
this Agreement and the indemnification provided for herein is unavailable to Indemnitee for any reason whatsoever, the Companies,
in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties,
excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable
event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding
in order to reflect (i) the relative benefits received by the Companies and Indemnitee as a result of the event(s) and/or
transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Companies (and their respective directors,
officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).

 

9. Modification,
Waiver, Termination and Cancellation. No supplement, modification, termination, cancellation or amendment of this Agreement
shall be binding unless executed in writing by all of the parties hereto. No waiver of any of the provisions of this Agreement
shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar), nor shall such waiver constitute
a continuing waiver.

 

10. Subrogation.
In the event of any payment under this Agreement, the Companies shall be subrogated to the extent of such payment to all of the
rights of recovery of Indemnitee, who shall execute all papers required and shall do everything that may be necessary to secure
such rights, including the execution of such documents necessary to enable the Companies effectively to bring suit to enforce such
rights.

 

11. Notice
by Indemnitee and Defense of Claim. Indemnitee shall promptly notify the Companies in writing upon being served with any summons,
citation, subpoena, complaint, indictment, information or other document relating to any matter, whether civil, criminal, administrative
or investigative for which such Indemnitee is entitled to indemnification or an advancement of expenses hereunder, but the omission
so to notify the Companies will not relieve it from any liability that it may have to Indemnitee if such omission does not prejudice
the Companies’ rights. If such omission does prejudice the Companies’ rights, the Companies will be relieved from liability
only to the extent of such prejudice. No such omission shall relieve the Companies of any liability they may otherwise have to
Indemnitee outside of this Agreement under applicable law, the Companies’ constitutive documents or any agreements.

 

    5

     

    

 

12. Notices.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received
hereunder (a) one business day after being sent for next business day delivery, fees prepaid, via a reputable international
overnight courier service, (b) upon delivery in the case of delivery by hand, or (c) on the date delivered in the place
of delivery if sent by email (with a written or electronic confirmation of delivery from the recipient, excluding any automated
response) prior to 5:00 p.m. Eastern time, otherwise on the next succeeding business day, in each case to the intended recipient
as set forth below:

 

	(a)	If
    to the Parent	Olivia Ventures,
    Inc.
	 	(prior to closing):	2255 Glades Road,
    Suite 324A
	 	 	Boca Raton, Florida
    33431
	 	 	Attn: [**]
	 	 	Email: [**]
	 	 	 
	(b)	If to Compass:	Compass Therapeutics
    LLC
	 	 	245 First Street,
    3rd Floor 
	 	 	Cambridge, MA 02142
	 	 	Attn: [**]
	 	 	Email: [**]
	 	 	 
	(c)	If
    to Indemnitee:	The address set
    forth on the signature page hereto.

 

or any party may change the address to
which notices, requests, demands, claims and other communications hereunder are to be delivered by giving the other parties notice
in the manner herein set forth.

 

13. Non-Exclusivity.
The rights of Indemnitee hereunder shall not be deemed exclusive of any other rights to which Indemnitee may be entitled under
applicable law, the Companies’ constitutive documents, or any agreements, vote of stockholders, resolution of the Boards
of Directors or otherwise with respect to any Proceeding (as hereinafter defined) associated with Indemnitee acting in his official
capacity as an officer and director of the Parent arising out of or pertaining to actions relating to the approval of and entering
into the Merger Agreement, the Transaction Documentation (as defined in the Merger Agreement), the Merger and each of the transactions
contemplated thereby, whether asserted or claimed prior to, at or after the Effective Time.

 

14. Certain
Definitions.

 

(a) “Expenses”
shall include all direct and indirect costs (including, without limitation, attorneys’ fees, retainers, court costs, transcripts,
fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery
service fees, all other disbursements or out-of-pocket expenses) actually and reasonably incurred in connection with either the
investigation, defense, settlement or appeal of a Proceeding or establishing or enforcing a right to indemnification under this
Agreement, applicable law or otherwise; provided, however, that “Expenses” shall not include any Liabilities.

 

(b) “Independent
Legal Counsel” means a law firm or a member of a firm selected by the Companies and approved by Indemnitee (which approval
shall not be unreasonably withheld). Notwithstanding the foregoing, the term “Independent Legal Counsel” shall not
include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest
in representing either the Companies or Indemnitee in an action to determine Indemnitee’s right to indemnification under
this Agreement.

 

    6

     

    

 

(c) “Liabilities”
means liabilities of any type whatsoever including, but not limited to, any judgments, fines, ERISA excise taxes and penalties,
penalties and amounts paid in settlement (including all interest assessments and other charges paid or payable in connection with
or in respect of such judgments, fines, penalties or amounts paid in settlement) of any Proceeding.

 

(d) “Proceeding”
means any threatened, pending or completed action, claim, suit, arbitration, alternative dispute resolution mechanism, investigation,
administrative hearing or any other proceeding, whether civil, criminal, administrative or investigative, that (i) is asserted
or claimed or otherwise arises after the Effective Time, (ii) is associated with Indemnitee’s actions as an officer
and/or director of the Parent arising out of or pertaining to actions relating to the approval of and entering into the Merger
Agreement, the Transaction Documentation (as defined in the Merger Agreement), the Merger and each of the transactions contemplated
thereby, including any action brought by or in the right of the Parent or Compass, and (iii) is not initiated or brought by
the Indemnitee.

 

15. Binding
Effect; Duration and Scope of Agreement. This Agreement shall be binding upon and inure to the benefit of and be enforceable
by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger,
consolidation or otherwise to all or substantially all of the business or assets of the Companies), spouses, heirs and personal
and legal representatives. This Agreement shall continue in effect for six (6) years subsequent to the date of this Agreement,
regardless of whether Indemnitee continues to serve as director or an officer of the Parent.

 

16. Severability.
If any provision or provisions of this Agreement (or any portion thereof) shall be held to be invalid, illegal or unenforceable
for any reason whatsoever:

 

(a) the
validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired
thereby; and

 

(b) to
the fullest extent legally possible, the provisions of this Agreement shall be construed so as to give effect to the intent of
any provision held invalid, illegal or unenforceable.

 

17. Governing
Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, as
applied to contracts between Delaware residents entered into and to be performed entirely within the State of Delaware, without
regard to conflict of laws rules.

 

18. Consent
to Jurisdiction. The Companies and Indemnitee each irrevocably consent to the jurisdiction of the courts of the State of Delaware
for all purposes in connection with any action or Proceeding that arises out of or relates to this Agreement and agree that any
action instituted under this Agreement shall be brought only in the state courts of the State of Delaware.

 

19. Entire
Agreement. This Agreement represents the entire agreement between the parties hereto, and there are no other agreements, contracts
or understandings between the parties hereto with respect to the subject matter of this Agreement.

 

20. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but
all of which together shall constitute one and the same Agreement. This Agreement and any documents relating to it may be executed
and transmitted to any other party by email of a PDF, which PDF shall be deemed to be, and utilized in all respects as, an original,
wet-inked document.

 

[Signature Page Follows]

 

    7

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed as of the date first written above.

 

	OLIVIA VENTURES, INC.	 
	 	 
	By:	                                      	 
	Name: 	 	 
	Its:	 	 
	 	 
	COMPASS THERAPEUTICS LLC	 
	 	 
	By:	 	 
	Name:	 	 
	Its:	 	 
	 	 
	INDEMNITEE	 
	 	 
	By:	 	 
	Name:	 	 
	Address:  	 	 

 

[Signature Page to Indemnity Agreement]

 

 

8Exhibit 10.7

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration
Rights Agreement (this “Agreement”) is made and entered into effective as of June 19, 2020, among
Compass Therapeutics, Inc., a Delaware corporation (the “Company”), the persons who have purchased
the Offering Shares (as defined below) and have executed omnibus or counterpart signature page(s) hereto (each, a “Purchaser”
and collectively, the “Purchasers”), the persons or entities identified on Schedule 1 hereto
holding Merger Shares (as defined below), and the persons or entities identified on Schedule 2 hereto holding
Registrable Pre-Merger Shares (as defined below). Capitalized terms used herein shall have the meanings ascribed to them
in Section 1 below or in the Subscription Agreement (as defined below).

 

RECITALS:

 

WHEREAS, the
Company has offered and sold in compliance with Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated
under the Securities Act to accredited investors in a private placement offering (the “Offering”) shares
of the common stock of the Company, par value $0.0001 per share, pursuant to certain Subscription Agreements entered into by and
between the Company and each of the subscribers for the Offering Shares set forth on the signature pages affixed thereto (the “Subscription
Agreements”); and

 

WHEREAS, the
Company has agreed to enter into a registration rights agreement with each of the Purchasers in the Offering who purchased the
Offering Shares and those holders of Merger Shares or Registrable Pre-Merger Shares; and

 

WHEREAS, contemporaneously
with the initial closing of the Offering, a wholly owned subsidiary of the Company has merged with and into Compass Therapeutics
LLC, a Delaware limited liability company (“Compass”).

 

NOW, THEREFORE,
in consideration of the mutual promises, representations, warranties, covenants, and conditions set forth herein, the parties mutually
agree as follows:

 

1. Certain
Definitions. As used in this Agreement, the following terms shall have the following respective meanings:

 

“Approved
Market” means the OTCQB, OTCQX, the Nasdaq Stock Market, the New York Stock Exchange or the NYSE American.

 

“Blackout
Period” means, with respect to a distribution or registration, a period during which the Company, in the good faith
judgment of its board of directors, determines (because of the existence of, or in anticipation of, any acquisition, financing
activity, receipt of clinical trial results or other material corporate development or other material transaction involving the
Company, or the unavailability for reasons beyond the Company’s control of any required financial statements, disclosure
of material information which is in its best interest not to publicly disclose, or any other event or condition of similar material
significance to the Company) that the registration and/or distribution of the Registrable Securities to be covered by such registration
statement, if any, or the circumstances described in Section 4(j) below, would be seriously detrimental to the Company and
its stockholders, in each case commencing on the day the Company notifies the Holders that they are required, because of the determination
described above, to suspend offers and sales of Registrable Securities and ending on the earlier of (1) the date upon which
the material non-public information resulting in the Blackout Period is disclosed to the public or ceases to be material
and (2) such time as the Company notifies the selling Holders that sales pursuant to such Registration Statement or a new
or amended Registration Statement may resume; provided, however, that the aggregate of all Blackout Periods
shall not exceed ninety (90) Trading Days in any twelve (12) month period (except for Blackout Periods arising from the
filing of a post-effective amendment to the Registration Statement to update the prospectus therein to include the information
contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q or Periodic Reports on Form 8-K, which
Blackout Period may extend for the amount of time reasonably required to respond to comments of the staff of the Commission (the
“Staff”) on such amendment).

 

    

     

    

 

“Business
Day” means any day of the year, other than a Saturday, Sunday, or other day on which banks in the State of New York
are required or authorized to close.

 

“Commission”
means the U. S. Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

“Common
Stock” means the common stock, par value $0.0001 per share, of the Company and any and all shares of capital stock
or other equity securities of: (i) the Company which are added to or exchanged or substituted for the Common Stock by reason
of the declaration of any stock dividend or stock split, the issuance of any distribution or the reclassification, readjustment,
recapitalization or other such modification of the capital structure of the Company; and (ii) any other corporation, now or
hereafter organized under the laws of any state or other governmental authority, with which the Company is merged, which results
from any consolidation or reorganization to which the Company is a party, or to which is sold all or substantially all of the shares
or assets of the Company, if immediately after such merger, consolidation, reorganization or sale, the Company or the stockholders
of the Company own equity securities of such other corporation.

 

“Competitor”
means any person who is actively engaged in the primary business of the Company, which business constitutes a substantial part
of such person’s business activities; provided, that notwithstanding anything to the contrary herein, no person or affiliate
thereof that is primarily engaged in (or advises funds or other investment vehicles that are engaged in), making, purchasing, holding
or otherwise investing in equity securities, loans, notes, bonds or other debt securities in the ordinary course of business shall
be deemed a Competitor.

 

“Effective
Date” means the date of the final closing of the Offering.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder.

 

“Family
Member” means (a) with respect to any individual, such individual’s spouse, any descendants (whether natural
or adopted), any trust all of the beneficial interests of which are owned by any of such individuals or by any of such individuals
together with any organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, the estate
of any such individual, and any corporation, association, partnership or limited liability company all of the equity interests
of which are owned by those above described individuals, trusts or organizations and (b) with respect to any trust, the owners
of the beneficial interests of such trust.

 

    2

     

    

 

“Holder”
means (i) each Purchaser or any of such Purchaser’s respective successors and Permitted Assignees who acquire rights
in accordance with this Agreement with respect to any Registrable Securities directly or indirectly from a Purchaser or from any
Permitted Assignee; (ii) each holder of Registrable Pre-Merger Shares or its respective successors and Permitted Assignees
who acquire rights in accordance with this Agreement with respect to any Registrable Securities directly or indirectly from such
holder or from any Permitted Assignee thereof; and (iii) each holder of the Merger Shares or its respective successors and
Permitted Assignees who acquire rights in accordance with this Agreement with respect to any Registrable Securities directly or
indirectly from such holder or from any Permitted Assignee thereof.

 

“Majority
Holders” means, at any time, Holders of both (i) a majority of the Registrable Securities then outstanding and (ii)
a majority of the Offering Shares then outstanding that constitute Registrable Securities.

 

“Merger
Shares” means the 39,055,638 shares of Common Stock issued or issuable in exchange for all of the equity units of
Compass that are outstanding immediately prior to the closing of the Merger (inclusive of the shares of Common Stock issuable or
issued pursuant to the Blocker Mergers), and any shares of Common Stock issued or issuable with respect to such shares upon any
stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing.

 

“Permitted
Assignee” means (a) with respect to a partnership, its partners or former partners in accordance with their
partnership interests, (b) with respect to a corporation, its stockholders in accordance with their interest in the corporation,
(c) with respect to a limited liability company, its members or former members in accordance with their interest in the limited
liability company, (d) with respect to an individual party, any Family Member of such party and any trust for the direct or
indirect benefit of an individual or a Family Member of such individual, (e) with respect to a trust, to the trustor or beneficiary
of such trust or to the estate of a beneficiary of such trust, (f) an entity or trust that is controlled by, controls, or
is under common control with a transferor, (g) any affiliate of a transferor in any transaction in which the transferor distributes
Restricted Securities to such affiliate for no consideration, (h) a party to this Agreement or (i) any transferee that is
not a Competitor of the Company at the time of such transfer.

 

“Offering
Shares” means the shares of Common Stock issued to the Purchasers pursuant to the Subscription Agreements, and any
shares of Common Stock issued or issuable with respect to such shares upon any stock split, dividend or other distribution, recapitalization
or similar event with respect to the foregoing.

 

The terms “register,”
“registered,” and “registration” refer to a registration effected by preparing
and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness
of such registration statement.

 

    3

     

    

 

“Registrable Pre-Merger Shares”
means 1,000,000 shares of Common Stock of the Company held by stockholders of the Company prior to the Merger and remaining outstanding
immediately following the effective time of the Merger, and any shares of Common Stock issued or issuable with respect to such
shares upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing.

 

“Registrable Pre-Merger Stockholder”
means a person holding Registrable Pre-Merger Shares immediately prior to the effective time of the Merger.

 

“Registrable
Securities” means (a) the Offering Shares, (b) the Merger Shares, (c) the Registrable Pre-Merger Shares
and (d) other shares of Restricted Common Stock held by the Holders, whether hereinafter acquired or issuable in respect of such
Common Shares by way of conversion, dividend, stock-split, distribution or exchange, merger, consolidation, recapitalization or
reclassification or similar transaction; but, in each case, excluding any otherwise Registrable Securities that (i) have been
sold or otherwise transferred other than to a Permitted Assignee or (ii) have been sold under Rule 144 of the Securities Act.

 

“Registration
Default Period” means the period beginning on the date of which any Registration Event occurs and ending on the date
on which such Registration Event is cured, inclusive.

 

“Registration
Effectiveness Date” means the date that is one hundred and fifty (150) calendar days after the Effective Date, which
one hundred and fifty day period shall be extended for each day of a U.S. government shut down that results in the Commission temporarily
discontinuing review of, or acceleration of the effectiveness of, registration statements, if any.

 

“Registration
Event” means the occurrence of any of the following events:

 

(a) the
Company fails to file with the Commission the Registration Statement on or before the Registration Filing Date;

 

(b) the
Registration Statement is not declared effective by the Commission on or before the Registration Effectiveness Date;

 

(c) after
the SEC Effective Date, the Registration Statement ceases for any reason to remain continuously effective or the Holders are otherwise
not permitted to utilize the prospectus therein to resell the Registrable Securities for a period of more than fifteen (15) consecutive
Trading Days, except for Blackout Periods permitted herein; or

 

(d) following
the listing or inclusion for quotation on an Approved Market, the Registrable Securities, if issued and outstanding, are not listed
or included for quotation on an Approved Market, or trading of the Common Stock is suspended or halted on the Approved Market,
which at the time constitutes the principal markets for the Common Stock, for more than three (3) full, consecutive Trading
Days; provided, however, a Registration Event shall not be deemed to occur if all or substantially all trading in equity securities
(including the Common Stock) is suspended or halted on the Approved Market for any length of time.

 

    4

     

    

 

“Registration
Filing Date” means the date that is sixty (60) calendar days after the Effective Date.

 

“Registration
Statement” means any registration statement that the Company is required to file pursuant to Section 3(a) of
this Agreement to register the Registrable Securities and any successor registration statement.

 

“Restricted
Common Stock” means any shares of Common Stock that are subject to resale restrictions pursuant to the Securities
Act and the rules and regulations promulgated thereunder, including, but not limited to, securities: (1) acquired directly or indirectly
from the issuer or an affiliate of the issuer in unregistered offerings such as private placements; (2) acquired through an employee
stock benefit plan or as compensation for professional services; or (3) considered “restricted securities” under Rule
144. For purposes of clarity Restricted Common Stock does not include Common Stock that is restricted solely as a result of contractual
restrictions, including but not limited to lock-up or similar contractual agreements.

 

“Rule
144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented
from time to time, or any similar successor rule that may be promulgated by the Commission.

 

“Rule
145” means Rule 145 promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented
from time to time, or any similar successor rule that may be promulgated by the Commission.

 

“Rule
415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended or supplemented
from time to time, or any similar successor rule that may be promulgated by the Commission.

 

“Securities
Act” means the Securities Act of 1933, as amended, or any similar federal statute promulgated in replacement thereof,
and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time.

 

“SEC Effective
Date” means the date the Registration Statement is declared effective by the Commission.

 

“Trading
Day” means any day on which the Approved Market that at the time constitutes the principal securities market for
the Common Stock, is open for general trading of securities (or if there is no Approved Market that at the time constitutes the
principal securities market for the Common Stock, then any day on which the New York Stock Exchange is open for general trading
of securities).

 

2. Term.
This Agreement shall terminate with respect to each Holder on the earlier of: (i) the date that is five (5) years from
the SEC Effective Date and (ii) the date on which all Registrable Securities held by such Holder have been transferred other
than to a Permitted Assignee (the “Term”). Notwithstanding the foregoing, Section 3(b), Section 6,
Section 8, Section 9 and Section 10 shall survive the termination of this Agreement.

 

    5

     

    

 

3. Registration.

 

(a) Registration
on Form S-1. The Company shall prepare and file with the Commission a Registration Statement on Form S-1, Form S-3, or
any other form for which the Company then qualifies or which counsel for the Company shall deem appropriate and which form shall
be available for the resale by the Holders of all of the Registrable Securities on a delayed or continuous basis (including in
stock exchange transactions and underwritten offerings), and the Company shall (i) make the initial filing of the Registration
Statement with the Commission no later than the Registration Filing Date, (ii)  use its commercially reasonable efforts to
cause such Registration Statement to be declared effective no later than the Registration Effectiveness Date and (iii) use
its commercially reasonable efforts to keep such Registration Statement if on Form S-3 continuously effective (including by filing
a new Registration Statement if the initial Registration Statement expires) for a period of five (5) years after the SEC Effective
Date or for such shorter period ending on the date on which all Registrable Securities have been transferred other than to a Permitted
Assignee (the “Effectiveness Period”); provided, however, that the Company shall
not be obligated to effect any such registration, qualification or compliance pursuant to this Section 3(a), or keep such registration
effective pursuant to the terms hereunder, in any particular jurisdiction in which the Company would be required to qualify to
do business as a foreign corporation or as a dealer in securities under the securities laws of such jurisdiction or to execute
a general consent to service of process in effecting such registration, qualification or compliance, in each case where it has
not already done so. Upon the Company becoming eligible to register the Registrable Securities for resale by the Holders on Form
S-3, the Company shall use commercially reasonable efforts to amend the Registration Statement to a Registration Statement on Form
S-3 or file a Registration Statement on Form S-3 in substitution of the Registration Statement as initially filed as soon as reasonably
practicable thereafter. The Company shall be entitled to suspend the effectiveness of the Registration Statement during a Blackout
Period for the reasons and time periods set forth in the definition thereof. After the SEC Effective Date, any Holder whose securities
were registered pursuant to Registration Statement may at any time and from time to time request in writing to sell pursuant to
a prospectus or a prospectus supplement Registrable Securities of such Holder available for sale pursuant to the Registration Statement.
If the Company is not in a Blackout Period, the Company shall use its commercially reasonable efforts to, not later than the fifth
Trading Day after the receipt of such notice cause to be filed the prospectus or a prospectus supplement; provided any request
for a prospectus supplement may be withdrawn by the initiating Holder prior to the filing thereof. If the Company is in a Blackout
Period during the time such request is made, the Company shall use its commercially reasonable efforts to, not later than the fifth
Trading Day after the cessation of the Blackout Period to cause to be filed the prospectus or a prospectus supplement; provided
any request for a prospectus supplement may be withdrawn by the initiating Holder prior to the filing thereof. The Company shall
amend or supplement the Registration Statement as may be necessary in order to enable the inclusion of Registrable Securities by
any Holder upon receipt of a written request by such Holder. Notwithstanding the foregoing, in the event that the Staff should
limit the number of Registrable Securities that may be sold pursuant to the Registration Statement, the Company may remove from
the Registration Statement such number of Registrable Securities as specified by the Commission on behalf of all of the holders
of Registrable Securities from the Registrable Securities on a pro rata basis among the holders thereof (such Registrable Securities,
the “Reduction Securities”). In such event, the Company shall give the Holders prompt notice of the number
of Registrable Securities excluded from the Registration Statement. The Company shall use its commercially reasonable efforts at
the first opportunity that is permitted by the Commission to, register for resale the Reduction Securities (pro rata among the
Holders of such Reduction Securities) using one or more Registration Statements that it is then entitled to use; provided, however,
that the Company shall not be required to register such Reduction Securities during a Blackout Period. The Company shall use its
commercially reasonable efforts to cause each such Registration Statement to be declared effective under the Securities Act as
soon as possible, and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective
(including by filing a new Registration Statement if the initial Registration Statement expires) under the Securities Act during
the entire Effectiveness Period. Notwithstanding the foregoing, the Company shall be entitled to suspend the effectiveness of such
Registration Statement at any time prior to the expiration of the Effectiveness Period for the reasons and time periods during
a Blackout Period. No liquidated damages shall accrue or be payable to any Holder pursuant to Section 3(b) below with respect
to any Registrable Securities that are excluded by reason of (i) the Staff limiting the number of Registrable Securities that may
be sold pursuant to a registration statement (provided that the Company continues to use commercially reasonable efforts to register
such Reduction Securities for resale by other available means) or (ii) such Holder failing to provide to the Company information
concerning the Holder and the manner of distribution of the Holder’s Registrable Securities that is required by the SEC or
in response to SEC comments to be disclosed in a registration statement utilized in connection with the registration of registrable
securities. Notwithstanding anything herein to the contrary, if the Commission limits the Company’s ability to file, or prohibits
or delays the filing of a new registration statement, the Company’s compliance with such limitation, prohibition or delay
solely to the extent of such limitation, prohibition or delay shall not be deemed a failure by the Company to use commercially
reasonable efforts as set forth above or elsewhere in this Agreement and shall not require the payment of any liquidated damages
by the Company under this Agreement.

 

    6

     

    

 

(b) Liquidated
Damages. If a Registration Event occurs, then the Company will make payments to each Holder of Registrable Securities, as liquidated
damages to such Holder by reason of the Registration Event, a cash sum calculated at a rate of twelve percent (12%) per annum of
the total of the following, to the extent applicable to such Holder: (i) if the Holder purchased Registrable Securities pursuant
to a Subscription Agreement, the aggregate purchase price paid by such Holder pursuant to the Subscription Agreement for the Registrable
Securities held by such Holder as of the date of such Registration Event, or (ii) if the Holder is a Holder of Merger
Shares or Registrable Pre-Merger Shares, the product of $5.00 (as adjusted for stock splits, stock dividends, combinations,
recapitalizations or similar events) multiplied by the number of Merger Shares or Registrable Pre-Merger Shares held
by such Holder as of the date of such Registration Event, but in the case of each of clauses (i) and (ii) above, only with respect
to such Holder’s Registrable Securities that are affected by such Registration Event and only for the applicable Registration
Default Period. Notwithstanding the foregoing, the maximum amount of liquidated damages that may be paid by the Company pursuant
to this Section 3(b) shall be an amount equal to five percent (5%) of the applicable foregoing amounts described in clauses
(i) and (ii) in the preceding sentence with respect to such Holder’s Registrable Securities that are affected by all
Registration Events in the aggregate. For clarity, and by way of example, if the sum of clauses (i) and (ii) for a specified Holder
in the first sentence of this Section 3(b) is $10,000,000, liquidated damages payable by the Company to such Holder by reason of
one or more Registration Events affecting all Registrable Securities of such Holder would accrue at a rate of twelve percent (12%)
per annum until such time that all liquidated damages payable to such Holder reached a cap of $500,000 in the aggregate for all
Registration Events. Each payment of liquidated damages pursuant to this Section 3(b) shall be due and payable in cash in
arrears within five (5) days after the end of each full 30-day period of the Registration Default Period until the
termination of the Registration Default Period and within five (5) days after such termination. Until the maximum amount of
liquidated damages is paid, such payments shall constitute the Holder’s sole and exclusive remedy for any Registration Event.
The Registration Default Period shall terminate upon the earlier of such time as the Registrable Securities that are affected by
the Registration Event cease to be Registrable Securities or (i) the filing of the Registration Statement in the case of clause
(a) of the definition of Registration Event, (ii) the SEC Effective Date in the case of clause (b) of the definition
of Registration Event, (iii) the ability of the Holders to effect sales pursuant to the Registration Statement in the case
of clause (c) of the definition of Registration Event, and (iv) the listing or inclusion and/or trading of the Common
Stock on an Approved Market, as the case may be, in the case of clause (d) of the definition of Registration Event; provided, that
in the event of a cure of one or more of the Registration Events described in clauses (i)-(iv) above when a separate Registration
Event shall be continuing, the Registration Default Period shall continue until all such Registration Events have ceased. The amounts
payable as liquidated damages pursuant to this Section 3(b) shall be payable in lawful money of the United States.

 

    7

     

    

 

(c) Other
Limitations. Notwithstanding the provisions of Section 3(b) above, if the Commission does not declare the Registration
Statement effective on or before the Registration Effectiveness Date, and the reason for the Commission’s determination is
that (i) the offering of any of the Registrable Securities constitutes a primary offering of securities by the Company, (ii) Rule
415 may not be relied upon for the registration of the resale of any or all of the Registrable Securities, and/or (iii) a Holder
of any Registrable Securities must be named as an underwriter and such Holder does not consent to be so named in the Registration
Statement, the Holders shall not be entitled to liquidated damages with respect to the Registrable Securities not registered; provided
that the Company continues to use its commercially reasonable efforts at the first opportunity that is permitted by the Commission
to register for resale all such Registrable Securities, using one or more registration statements that it is then entitled to use.
The Company shall use its commercially reasonable efforts to cause each such registration statement to be declared effective under
the Securities Act as soon as possible, and shall use its commercially reasonable efforts to keep such registration statement continuously
effective under the Securities Act during the entire Effectiveness Period. Notwithstanding the foregoing, the Company shall be
entitled to suspend the effectiveness of such Registration Statement at any time prior to the expiration of the Effectiveness Period
for the reasons and time periods during a Blackout Period. No liquidated damages shall accrue or be payable to any Holder with
respect to any Registrable Securities that are excluded by reason of the Staff limiting the number of Registrable Securities that
may be sold pursuant to a registration statement; provided that the Company continues to use commercially reasonable efforts to
register such Registrable Securities for resale by other available means. Notwithstanding anything herein to the contrary, if the
Commission limits the Company’s ability to file, or prohibits or delays the filing of a new registration statement, the Company’s
compliance with such limitation, prohibition or delay solely to the extent of such limitation, prohibition or delay shall not be
deemed a failure by the Company to use commercially reasonable efforts as set forth above or elsewhere in this Agreement and shall
not require the payment of any liquidated damages by the Company under this Agreement.

 

    8

     

    

 

(d)  Secondary
Offering. If the Company receives a written notice from a Holder or Holders of the Registrable Securities then outstanding
(the “Requesting Holders”) that they desire to distribute Registrable Securities held by them (or a portion
thereof) of at least (i) 3,000,000 shares of Registrable Securities (as adjusted for any stock split, dividend, combination or
other recapitalization from the date hereof) or (ii) an estimated market value of at least $10,000,000, in either case by means
of an underwritten offering or a block trade (a “Secondary Offering”), the Company shall: (i) use commercially
reasonable efforts to promptly engage one or more underwriter(s) or investment bank(s) to conduct such Secondary Offering; and
(ii) promptly give notice of such Secondary Offering (each such request shall be referred to herein as a “Demand Takedown”)
at least ten (10) Business Days prior to the anticipated filing date of the prospectus or supplement relating to such Secondary
Offering to the other Holders and thereupon shall use its commercially reasonable efforts to effect, as expeditiously as possible,
the offering in such Secondary Offering of: (A) subject to the restrictions set forth in this Section 3(d), all Registrable Securities
for which the Requesting Holders have requested to be included in such Secondary Offering, and (B) subject to the restrictions
set forth in this Section 3(d), all other Registrable Securities that any other Holders (all such other Holders, together with
the Requesting Holders, the “Selling Holders”) have requested the Company to offer in such Secondary
Offering by request received by the Company within five (5) Business Days after the Company has delivered notice of the Demand
Takedown, all to the extent necessary to permit the disposition (in accordance with the intended methods thereof as aforesaid)
of the Registrable Securities so to be offered. The Company shall only be required to effectuate one Secondary Offering within
any six-month period. The underwriter(s) or investment bank(s) will be selected by the Holders of a majority of the Registrable
Securities held by all Holders providing such notice and reasonably acceptable to the Company (such approval not to be unreasonably
conditioned, withheld or delayed). All Holders proposing to distribute their securities through such Secondary Offering shall enter
into an underwriting agreement or other agreement(s), including, if requested by the managing underwriter or investment bank, any
lock-up or market standoff agreements, in customary form with the underwriter(s) or investment bank(s) selected for such Secondary
Offering as may be mutually agreed upon among the Company, the underwriter(s) or investment bank(s) and Holders of a majority of
the Registrable Securities to be offered in such Secondary Offering. In connection with a Secondary Offering, the Company shall
enter into and perform its obligations under an underwriting agreement or other agreement(s), in usual and customary form as may
be mutually agreed upon among the Company, the underwriter(s) or investment bank(s) and the Holders of a majority of the Registrable
Securities to be included in such Secondary Offering. Notwithstanding any other provision of this Section 3(d), if the managing
underwriter in good faith advises the Selling Holders and the Company in writing that the inclusion of all Registrable Securities
proposed to be included by the Selling Holders would materially and adversely interfere with the successful marketing of such offering,
then the number of shares, including the Registrable Securities, that may be included in such Secondary Offering shall be allocated
among such Holders of Registrable Securities, and any other holders of shares, as follows: (i) first, the Registrable Securities
to be included in such Secondary Offering by the Selling Holders in proportion (as nearly as practicable) to the number of Registrable
Securities proposed to be sold by each such Selling Holder or in such other proportion as shall mutually be agreed to by all such
Selling Holders; and (ii) second to the Company, if the Company desires to sell any shares of Common Stock or other securities
in such offering and (iii) third to all other holders of securities included in the Secondary Offering. The provisions of this
Section 3(d) shall apply, mutatis mutandis, to any future registration rights agreements entered into by the Company such
that the Company shall be required to give notice of a Secondary Offering (or equivalent term) under such other registration rights
agreement to Holders and permit Holders to participate in such Secondary Offering as Selling Holders.

 

    9

     

    

 

4. Registration
Procedures. The Company will keep each Holder reasonably advised as to the filing and effectiveness of the Registration Statement.
At its expense with respect to the Registration Statement, the Company will:

 

(a) subject
to compliance with Section 5(b), prepare and file with the Commission with respect to the Registrable Securities, the Registration
Statement in accordance with Section 3(a) hereof, and use its commercially reasonable efforts to cause such Registration Statement
to become effective and to remain effective for the Effectiveness Period;

 

(b) not
name any Holder in the Registration Statement as an underwriter without that Holder’s prior written consent;

 

(c) provide any Holder,
any underwriter participating in any disposition pursuant to a Registration Statement, and any attorney, accountant or other agent
retained by any Holder or underwriter (each, an “Inspector” and, collectively, the “Inspectors”),
the reasonable opportunity to review and comment on such Registration Statement, each prospectus included therein or filed with
the Commission and each amendment or supplement thereto;

 

(d) for a reasonable
period prior to the filing of the Registration Statement pursuant to this Agreement, make available for inspection and copying
by the Inspectors such financial and other information and books and records, pertinent corporate documents and properties of the
Company and its subsidiaries and cause the officers, directors, employees, counsel and independent certified public accountants
of the Company and its subsidiaries to respond to such inquiries and to supply all information reasonably requested by any such
Inspector in connection with such Registration Statement, as shall be reasonably necessary, to conduct a reasonable investigation
within the meaning of the Securities Act;

 

(e) if
the Registration Statement or any post-effective amendment thereto is subject to review by the Commission, promptly respond to
all comments, diligently pursue resolution of any comments to the satisfaction of the Commission and file all amendments and supplements
to such Registration Statement as may be required to respond to comments from the Commission and otherwise to enable such Registration
Statement to be declared effective;

 

(f) during
the Effectiveness Period, prepare and file with the Commission such amendments and supplements to such Registration Statement as
may be necessary to keep such Registration Statement continuously effective, current and up-to-date for the applicable time period
required hereunder and, if applicable, file any Registration Statement pursuant to Rule 462(b) under the Securities Act; cause
the related prospectus to be supplemented by any required prospectus supplement, and as so supplemented to be filed pursuant to
Rule 424 (or any similar provisions then in force) promulgated under the Securities Act;

 

(g) not
less than ten (10) Trading Days prior to filing the Registration Statement or any related prospectus or any amendment or supplement
thereto, the Company shall furnish to the Holders (or, if so specified by any Holder, legal counsel to such Holder) copies of or
a link to all such documents proposed to be filed (other than those incorporated by reference) and duly consider in good faith
any comments received from the Holders (or from legal counsel to such Holders, as applicable);

 

    10

     

    

 

(h) furnish,
without charge, to each Holder of Registrable Securities covered by such Registration Statement (i) a reasonable number of
copies of such Registration Statement (including any exhibits thereto other than exhibits incorporated by reference), each amendment
and supplement thereto as such Holder may reasonably request, (ii) such number of copies of the prospectus included in such
Registration Statement (including each preliminary prospectus and any other prospectus filed under Rule 424 of the Securities Act)
as such Holders may reasonably request, in conformity with the requirements of the Securities Act, and (iii) such other documents
as such Holder may reasonably require to consummate the disposition of the Registrable Securities owned by such Holder, but only
during the Effectiveness Period; provided that the Company shall have no obligation to furnish any document pursuant to this clause
that is available on the Electronic Data Gathering, Analysis, and Retrieval (“EDGAR”) system;

 

(i) use
its reasonable best efforts to register or qualify the securities covered by such Registration Statement under such other applicable
securities laws of such jurisdictions within the United States, including Blue Sky laws, as any Holder of Registrable Securities
covered by such Registration Statement reasonably requests and as may be reasonably necessary for the marketability of the Registrable
Securities (such request to be made by the time the applicable Registration Statement is deemed effective by the Commission) and
do any and all other acts and things reasonably necessary to enable such Holder to consummate the disposition in such jurisdictions
of the Registrable Securities owned by such Holder; provided, that the Company shall not be required to (i) qualify
generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this paragraph or (ii)
consent to general service of process in any such jurisdiction where it has not already done so;

 

(j) as
promptly as practicable after becoming aware of any event, notify each Holder of Registrable Securities at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of the happening of any event that will, after the occurrence
of such event, cause the prospectus included in such Registration Statement, if not amended or supplemented, to contain an untrue
statement of a material fact or an omission to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading and the Company shall promptly thereafter
prepare and furnish to such Holder a supplement or amendment to such prospectus (or prepare and file appropriate reports under
the Exchange Act) so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not
contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading, unless suspension of
the use of such prospectus otherwise is authorized herein or in the event of a Blackout Period, in which case no supplement or
amendment need be furnished (or Exchange Act filing made) until the termination of such suspension or Blackout Period; provided
that any and all information provided to the Holder pursuant to such notification shall remain confidential to each Holder until
such information otherwise becomes public, unless disclosure by a Holder is required by law;

 

(k) comply,
and continue to comply during the Effectiveness Period, in all material respects with the Securities Act and the Exchange Act
and with all applicable rules and regulations of the Commission with respect to the disposition of all securities covered by such
Registration Statement;

 

    11

     

    

 

(l) as
promptly as practicable after becoming aware of such event, notify each Holder of Registrable Securities being offered or sold
pursuant to the Registration Statement of the issuance by the Commission or any other federal or state governmental authority of
any stop order or other suspension of effectiveness of the Registration Statement or the initiation of any proceedings for that
purpose;

 

(m) use commercially
reasonable efforts to obtain all other approvals, consents, exemptions or authorizations from such governmental agencies or authorities
as may be necessary to enable the Holders and underwriters to consummate the disposition of Registrable Securities;

 

(n) enter into customary
agreements (including any underwriting agreements in customary form, including any representations and warranties and lock-up provisions
therein), and take such other actions as may be reasonably required in order to expedite or facilitate the disposition of Registrable
Securities;

 

(o) use
its commercially reasonable efforts to furnish, or cause to be furnished, on the date that such Registrable Securities are delivered
to the underwriters for sale, if such securities are being sold through underwriters, (i) an opinion, dated as of such date, of
the counsel representing the Company for the purposes of such registration, in form and substance reasonably acceptable to the
managing underwriter, addressed to the underwriters and (ii) a “comfort” letter dated as of such date, from the independent
certified public accountants of the Company, in form and substance reasonably acceptable to the managing underwriter, addressed
to the underwriters;

 

(p) use commercially
reasonable efforts to comply with all applicable rules and regulations of the Commission and make available to its shareholders,
as soon as reasonably practicable, but no later than sixteen (16) months after the effective date of any Registration Statement
(as defined in Rule 168(c) under the Securities Act), an earnings statement that satisfies the provisions of Section 11(a) of the
Securities Act and Rule 158 thereunder;

 

(q) provide officers’
certificates and other customary closing documents;

 

(r) use
its commercially reasonable efforts to cause the shares of Common Stock to be quoted or listed on an Approved Market;

 

(s) cooperate
with each Holder and each underwriter participating in the disposition of such Registrable Securities and underwriters’ counsel
in connection with any filings required to be made with the Financial Industry Regulatory Authority (“FINRA”)
and file a Form 15c2-11 with FINRA no later than the Registration Filing Date;

 

(t) cause appropriate
officers as are reasonably requested by a managing underwriter or investment bank to participate in a “road show” or
similar marketing effort being conducted by such underwriter with respect to an underwritten public offering;

 

(u) provide
a transfer agent and registrar, which may be a single entity, for the shares of Common Stock at all times, and cooperate with the
Holders to facilitate the timely preparation and delivery of the Registrable Securities to be delivered to a transferee pursuant
to a resale of Registrable Securities pursuant to the Registration Statement (whether electronically or in certificated form) which
Registrable Securities shall be free, to the extent permitted by the applicable Subscription Agreement, of all restrictive legends,
and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may request;

 

    12

     

    

 

(v) cooperate
with the Holders of Registrable Securities being offered pursuant to the Registration Statement to issue and deliver, or cause
its transfer agent to issue and deliver, certificates representing Registrable Securities to be offered pursuant to the Registration
Statement within a reasonable time after the delivery of certificates representing the Registrable Securities to the transfer agent
or the Company, as applicable, and enable such certificates to be in such denominations or amounts as the Holders may reasonably
request and registered in such names as the Holders may request;

 

(w) notify
the Holders, the Placement Agents and their counsel as promptly as reasonably possible and (if requested by any such Person) confirm
such notice in writing: (i)(A) when a Prospectus or any prospectus supplement or post-effective amendment to a Registration Statement
is proposed to be filed; (B) when the Commission notifies the Company whether there will be a “no review,” “review”
or a “completion of a review” of such Registration Statement and whenever the Commission comments in writing on such
Registration Statement (in which case the Company shall provide true and complete copies thereof and all written responses thereto
to each of the Holders that pertain to the Holders as a selling stockholder, but not information which the Company believes would
constitute material and non-public information); and (C) with respect to the Registration Statement or any post-effective
amendment, when the same has been declared effective, provided, however, that such notice under this clause (C) shall be delivered
to each Holder; (ii) during the Effectiveness Period, of any request by the Commission or any other federal or state governmental
authority for amendments or supplements to a Registration Statement or prospectus or for additional information that pertains to
the Holders as selling stockholders; or (iii) during the Effectiveness Period, of the receipt by the Company of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale
in any jurisdiction, or the initiation or threatening of any proceeding for such purpose;

 

(x) during
the Effectiveness Period, refrain from bidding for or purchasing any Common Stock or any right to purchase Common Stock or attempting
to induce any person to purchase any such security or right if such bid, purchase or attempt would in any way limit the right of
the Holders to sell Registrable Securities by reason of the limitations set forth in Regulation M of the Exchange Act;

 

(y) use
its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or
suspending the effectiveness of a Registration Statement or suspending or preventing the use of any related prospectus, or (ii)
any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction,
at the earliest practicable moment;

 

(z) use commercially
reasonable efforts to assist a Holder in facilitating any sales (including but not limited to private sales) or other transfers
of Registrable Securities by, among other things, providing officers’ certificates and other customary closing documents
reasonably requested by a Holder;

 

(aa) cooperate
with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing with the FINRA
Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay the filing
fee required by such filing within two (2) Trading Days of the request therefor; and

 

    13

     

    

 

(bb) take
all other commercially reasonable actions necessary to enable, expedite or facilitate the Holders to dispose of the Registrable
Securities by means of the Registration Statement contemplated hereby during the Term.

 

5. Obligations
of the Holders.

 

(a) At
any time, and from time to time, after the Registration Effectiveness Date, the Company may notify one or more of the Holders (in
each case, the “Specified Holders”) in writing (each, a “Suspension Notice”) of the
happening of: (i) any event of the kind described in Section 4(j); (ii) any Blackout Period; or (iii) only with respect to a Holder
who is an “insider” covered by such program, any suspension by the Company, pursuant to a written insider trading compliance
program adopted by the Company’s Board of Directors, of the ability of all “insiders” covered by such program
to transact in the Company’s securities because of the existence of material non-public information (each, a “Suspension
Event”). Upon receipt of any Suspension Notice, each Specified Holder shall as promptly as practicable discontinue
disposition of such Holder’s Registrable Securities covered by the Registration Statement until such Specified Holder receives
the supplemented or amended prospectus contemplated by Section 4(h), such blackout period shall have terminated or the restriction
on the ability of “insiders” to transact in the Company’s securities is removed, as applicable, and, if so directed
by the Company, each such Specified Holder will deliver to the Company (at the Company’s expense) all copies, other than
permanent file copies then in such Specified Holder’s possession, of the most recent prospectus covering such Specified Holder’s
Registrable Securities at the time of receipt of such Suspension Notice. The foregoing right to delay or suspend may be exercised
by the Company for no longer than ninety (90) Trading Days in any consecutive 12-month period (and for the avoidance of doubt,
if the delay or suspension relates to a Blackout Period, the period of delay or suspension shall also count against the maximum
number of days for Blackout Periods in the definition of such term).

 

(b) The
Holders of the Registrable Securities shall provide such information as may reasonably be requested by the Company in connection
with the preparation of the Registration Statement, including amendments and supplements thereto, in order to effect the registration
of any Registrable Securities under the Securities Act pursuant to Section 3(a) of this Agreement and in connection with the
Company’s obligation to comply with federal and applicable state securities laws, including a completed questionnaire in
the form attached to this Agreement as Annex A (a “Selling Securityholder Questionnaire”).

 

(c) Each
Holder, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of the Registration Statement hereunder, unless such Holder has notified the Company
in writing of its election to exclude all of its Registrable Securities from such Registration Statement.

 

    14

     

    

 

6. Registration
Expenses. The Company shall pay all expenses arising from or incident to the performance of, or compliance with, this Agreement,
including, without limitation, (i) the Commission, stock exchange, OTC Markets Group, FINRA and other registration and filing fees,
(ii) rating agencies fees, (iii) all fees and expenses incurred in connection with complying with any securities or blue sky laws
(including reasonable and documented fees, charges and disbursements of counsel in connection with blue sky qualifications of the
Registrable Securities), (iv) all printing (including financial printer), messenger and delivery expenses, (v) the fees, charges
and disbursements of counsel to the Company and of its independent public accountants and any other accounting and legal fees,
charges and expenses incurred by the Company (including any expenses arising from any special audits or “comfort letters”
required in connection with or incident to any registration), (vi) the fees, charges and disbursements of any special experts retained
by the Company in connection with any registration pursuant to the terms of this Agreement, (vii) all internal expenses of the
Company (including all salaries and expenses of its officers and employees performing legal or accounting duties), (viii) the fees
and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange, (ix) Securities
Act liability insurance (if the Company elects to obtain such insurance), regardless of whether a Registration Statement filed
in connection with such registration is declared effective and (x) reasonable and documented fees, charges and disbursements of
a single counsel to the Holders in an amount not to exceed $35,000; provided, that, in any underwritten registration,
the Company shall have no obligation to pay any underwriting discounts, selling commissions or transfer taxes attributable to the
Registrable Securities being sold by the Holders thereof, which underwriting discounts, selling commissions and transfer taxes
shall be borne by such Holders. Except as provided in this Section 6 and Section 8 of this Agreement, the Company shall
not be responsible for the expenses of any attorney or other advisor employed by a Holder or for any other fees, disbursements
and expenses incurred by Holders not specifically agreed to in this Agreement.

 

7. Assignment
of Rights. No Holder may assign its rights under this Agreement to any party without the prior written consent of the Company; provided, however,
that any Holder may assign its rights under this Agreement without such consent (a) to a Permitted Assignee with respect to
the Registrable Securities transferred to such Permitted Assignee (which Registrable Securities continue to constitute Restricted
Common Stock following such assignment) as long as (i) such transfer or assignment is effected in accordance with applicable
securities laws; (ii) such transferee or assignee agrees in writing to become bound by and subject to the terms of this Agreement;
(iii) such Holder notifies the Company in writing of such transfer or assignment, stating the name and address of the transferee
or assignee and identifying the Registrable Securities with respect to which such rights are being transferred or assigned; and
(iv) such transfer shall be at least 100,000 shares of Registrable Securities (as adjusted for any stock split, dividend, combination
or other recapitalization from the date hereof); or (b) as otherwise permitted under the applicable Subscription Agreement.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Majority
Holders (other than by merger or consolidation or to an entity which acquires the Company including by way of acquiring all or
substantially all of the Company’s assets, which shall not require such consent).

 

    15

     

    

 

8. Indemnification.

 

(a) To
the fullest extent permitted by applicable law, the Company shall, and hereby does, indemnify and hold harmless, to the fullest
extent permitted by law, each Holder, its affiliates, directors, officers, stockholders, members, managers, partners, employees
and agents and each other person, if any, who controls or is under common control with such Holder within the meaning of Section 15
of the Securities Act (collectively, the “Holder Indemnified Parties”), against any and all losses, claims,
damages, liabilities, costs, expenses, judgments, fines, penalties, charges and amounts paid in settlement (or actions or proceedings,
whether commenced or threatened, in respect thereof) (collectively, “Losses”) that arise out of or are
based upon any untrue statement or alleged untrue statement of any material fact contained in any registration statement prepared
and filed by the Company under which Registrable Securities were registered under the Securities Act, any preliminary prospectus,
free writing prospectus as defined under Rule 433(d) of the Securities Act (“Free Writing Prospectus”),
any “testing-the-water” communication that is a written communication within the meaning of Rule 405 under the Securities
Act (“Testing the Water Communication”), any road show communication as defined in Rule 433(h) under
the Securities Act (“Road Show Communication”), final prospectus or summary prospectus contained therein,
or any amendment or supplement thereto, or arise out of or are based upon any omission or alleged omission to state therein a material
fact required to be stated or necessary to make the statements therein in light of the circumstances in which they were made not
misleading, and the Company shall reimburse the Holder Indemnified Parties for any legal or any other expenses reasonably incurred
by them in connection with investigating, defending or settling any such loss, claim, damage, liability, action or proceeding; provided, however,
that the Company shall not be liable in any such case (i) to the extent, but only to the extent, that any such loss, claim, damage,
liability (or action or proceeding in respect thereof) or expense arises out of or is based upon (x) an untrue statement in
or omission from such registration statement, any such preliminary prospectus, Free Writing Prospectus, Testing the Water Communication,
Road Show Communication, final prospectus, summary prospectus, amendment or supplement in reliance upon and in conformity with
written information included in the Selling Securityholder Questionnaire, attached hereto as Annex A, furnished by a Holder or
its representative (acting on such Holder’s behalf) to the Company expressly for use in the preparation thereof or (y) the
failure of a Holder to comply with the covenants and agreements contained in Section 5 hereof respecting the sale of Registrable
Securities. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Holder
Indemnified Parties and shall survive the transfer of such shares by the Holder.

 

(b) As
a condition to including Registrable Securities in the registration statement filed pursuant to this Agreement, each Holder agrees,
severally and not jointly, to be bound by the terms of this Section 8 and to indemnify and hold harmless, to the fullest extent
permitted by law, the Company, each of its directors, officers, partners, and each underwriter, if any, and each other person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act, against any Losses, insofar as such
Losses arise out of or are based upon any untrue statement of a material fact contained in any registration statement, any preliminary
prospectus, Free Writing prospectus, Testing the Water Communication, Road Show Communication, final prospectus, summary prospectus,
amendment or supplement thereto, or arise out of or are based upon the omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, to the extent, but only to the extent, that such untrue
statement or omission is included or omitted in reliance upon and in conformity with written information included in the Selling
Securityholder Questionnaire, attached hereto as Annex A, furnished by the Holder or its representative (acting on such Holder’s
behalf) to the Company expressly for use in the preparation thereof, and such Holder shall reimburse the Company, and its directors,
officers, partners, and any such controlling persons for any legal or other expenses reasonably incurred by them in connection
with investigating, defending, or settling any such loss, claim, damage, liability, action, or proceeding; provided, however,
that the indemnity obligation contained in this Section 8(b) shall in no event exceed the amount of the net proceeds received
by such Holder as a result of the sale of such Holder’s Registrable Securities pursuant to such registration statement. Such
indemnity shall remain in full force and effect, regardless of any investigation made by or on behalf of the Company or any such
director, officer or controlling person and shall survive the transfer by any Holder of such shares.

 

    16

     

    

 

(c) Promptly
after receipt by an indemnified party of notice of the commencement of any action or proceeding involving a claim referred to in
this Section 8 (including any governmental action), such indemnified party shall, if a claim in respect thereof is to be made
against an indemnifying party, give written notice to the indemnifying party of the commencement of such action; provided, however,
that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations
under this Section 8, except to the extent that the indemnifying party is actually prejudiced by such failure to give notice in
any material respect. In case any such action is brought against an indemnified party, unless in the reasonable judgment of counsel
to such indemnified party a conflict of interest between such indemnified party and indemnifying parties may exist or the indemnified
party may have defenses not available to the indemnifying party in respect of such claim, the indemnifying party shall be entitled
to participate in and to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party and, after
notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying
party shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by the latter in connection
with the defense thereof, unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified
and indemnifying parties arises in respect of such claim or the indemnified party may have defenses not available to the indemnifying
party in respect of such claim after the assumption of the defenses thereof or the indemnifying party fails to defend such claim
in a diligent manner, other than reasonable costs of investigation. Neither an indemnified party nor an indemnifying party shall
be liable for any settlement of any action or proceeding effected without its consent (which shall not be unreasonably withheld
or delayed). No indemnifying party shall, without the consent of the indemnified party, consent to entry of any judgment or enter
into any settlement, which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect of such claim or litigation. Notwithstanding anything to the contrary set forth
herein, and without limiting any of the rights set forth above, in any event any party shall have the right to retain, at its own
expense, counsel with respect to the defense of a claim. Each indemnified party shall furnish such information regarding itself
or the claim in question as an indemnifying party may reasonably request in writing and as shall be reasonably required in connection
with defense of such claim and litigation resulting therefrom.

 

(d) If an indemnifying
party does not or is not permitted to assume the defense of an action pursuant to Section 8(c) or in the case of the expense
reimbursement obligation set forth in Sections 8(a) and 8(b), the indemnification required by Sections 8(a) and 8(b) shall be
made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or Losses are incurred.

 

    17

     

    

 

(e) If
the indemnification provided for in Section s 8(a) and 8(b) is held by a court of competent jurisdiction to be unavailable
to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, the indemnifying party,
in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party
as a result of such loss, liability, claim, damage or expense (i) in such proportion as is appropriate to reflect the proportionate
relative fault of the indemnifying party on the one hand and the indemnified party on the other (determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact or omission relates to information supplied by
the indemnifying party or the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such untrue statement or omission), or (ii) if the allocation provided by clause (i) above is not
permitted by applicable law or provides a lesser sum to the indemnified party than the amount hereinafter calculated, then in such
proportion as is appropriate to reflect not only the proportionate relative fault of the indemnifying party and the indemnified
party, but also the relative benefits received by the indemnifying party on the one hand and the indemnified party on the other,
as well as any other relevant equitable considerations. Notwithstanding any other provision of this Section 8(e), no Holder
shall be required to contribute any amount in excess of the amount by which the net proceeds received by such Holder from the sale
of the Registrable Securities pursuant to the Registration Statement exceeds the amount of damages that such Holder has otherwise
been required to pay by reason of such untrue or alleged untrue statement of a material fact or omission, except in the case of
fraud or willful misconduct. No indemnified party guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any indemnifying party who was not guilty of such fraudulent misrepresentation.

 

(f) The
indemnity and contribution agreements contained in this Section 8 are in addition to any liability that the indemnifying parties
may have to the indemnified parties and are not in diminution or limitation of the indemnification provisions under the applicable
Subscription Agreement.

 

9. (a)
Rule 144. The Company shall file with the Commission “Form 10 information” (as defined in Rule 144(i)(3) under
the Securities Act) reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1)(i) as promptly as
practicable following the closing of the Merger. Following the Effective Date, the Company will use its commercially reasonable
efforts to timely file all reports required to be filed by the Company after the date hereof under the Exchange Act and the rules
and regulations adopted by the Commission thereunder, and if the Company is not required to file reports pursuant to such sections,
it will prepare and furnish to the Holders and make publicly available in accordance with Rule 144(c) such information as is required
for the Holders to sell shares of Common Stock under Rule 144.

 

(b) Stock Exchange
Listing. The Company shall use commercially reasonable efforts to cause the Common Stock to be registered under Section 12(b)
of the Exchange Act and listed on the Nasdaq Stock Market or the New York Stock Exchange as soon as practicable after the Company
meets all of the applicable listing criteria for any tier of such stock exchanges. For the avoidance of doubt, the Company’s
commercially reasonable efforts in connection with this Section 9(b) shall include any necessary stock-splits, reverse stock splits,
stock dividends or other corporate actions necessary or appropriate to obtain a listing. Except as otherwise provided herein,
all expenses in connection with the matters contemplated by this Section 9(b) shall be borne by the Company.

 

    18

     

    

 

10. Miscellaneous.

 

(a) Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the United States of America and the
State of New York, both substantive and remedial, without regard to New York conflicts of law principles. Any judicial proceeding
brought against either of the parties to this Agreement or any dispute arising out of this Agreement or any matter related hereto
shall be brought in the state or federal courts of the State of New York, New York County and, by its execution and delivery of
this Agreement, each party to this Agreement accepts the jurisdiction of such courts. The foregoing consent to jurisdiction shall
not be deemed to confer rights on any person other than the parties to this Agreement.

 

(b) Remedies.
Except as otherwise specifically set forth herein with respect to a Registration Event, in the event of a breach by the Company
or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in
addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall
be entitled to seek specific performance of its rights under this Agreement. Except as otherwise specifically set forth herein
with respect to a Registration Event, the Company and each Holder agree that monetary damages would not provide adequate compensation
for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that,
in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that
a remedy at law would be adequate.

 

(c) Successors
and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon,
the successors, Permitted Assignees, executors and administrators of the parties hereto.

 

(d) No
Inconsistent Agreements. The Company has not entered, as of the date hereof, and shall not enter, on or after the date of this
Agreement, into any agreement with respect to its securities that would have the effect of impairing the rights granted to the
Holders in this Agreement or otherwise conflicts with the provisions hereof.

 

(e) Entire
Agreement. This Agreement and the documents, instruments and other agreements specifically referred to herein or delivered
pursuant hereto (including the Subscription Agreements) constitute the full and entire understanding and agreement between the
parties with regard to the subjects hereof.

 

(f) Notices,
etc. All notices, consents, waivers, and other communications which are required or permitted under this Agreement shall be
in writing will be deemed given to a party (a) upon receipt, when personally delivered; (b) one (1) Business Day after
deposit with a nationally recognized overnight courier service with next day delivery specified, costs prepaid on the date of delivery,
if delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); (c) the
time of transmission if sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment if
such notice or communication is delivered prior to 5:00 P.M., New York City time, on a Trading Day, or the next Trading Day after
the date of transmission, if such notice or communication is delivered on a day that is not a Trading Day or later than 5:00 P.M.,
New York City time, on any Trading Day, provided confirmation of facsimile is mechanically or electronically generated and kept
on file by the sending party and confirmation of email is kept on file, whether electronically or otherwise, by the sending party
and the sending party does not receive an automatically generated message from the recipients email server that such e-mail could
not be delivered to such recipient; (d) the date received or rejected by the addressee, if sent by certified mail, return
receipt requested, postage prepaid; or (e) seven (7) days after the placement of the notice into the mails (first class postage
prepaid), to the party at the address, facsimile number, or e-mail address furnished by the such party,

 

    19

     

    

 

If to the Company,
to:

 

Compass
Therapeutics

245 First
Street, 3rd Floor

Cambridge,
MA 02142

Attention:
[**]

Email:
[**]

 

with copy
to:

 

Goodwin Procter LLP

100 Northern Avenue

Boston, MA 02210

Attention: [**]

E-Mail: [**]

 

if to a
Holder, to:

 

such Holder
at the address set forth on the signature page hereto or in the Company’s records;

 

or at such other address as any party shall
have furnished to the other parties in writing in accordance with this Section 10(h).

 

(g) Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any Holder, upon any breach or default
of the Company under this Agreement, shall impair any such right, power or remedy of such Holder nor shall it be construed to be
a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereunder occurring; nor
shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring.
Any waiver, permit, consent or approval of any kind or character on the part of any Holder of any breach or default under this
Agreement, or any waiver on the part of any Holder of any provisions or conditions of this Agreement, must be in writing and shall
be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, or by law or
otherwise afforded to any holder, shall be cumulative and not alternative.

 

(h) Counterparts.
This Agreement may be executed in any number of counterparts, and with respect to any Purchaser, by execution of an Omnibus Signature
Page to this Agreement and the applicable Subscription Agreement, each of which shall be enforceable against the parties actually
executing such counterparts, and all of which together shall constitute one instrument. In the event that any signature is delivered
by facsimile transmission or by an e-mail, which contains a copy of an executed signature page such as a portable document
format (.pdf) file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such facsimile or e-mail of an executed signature page such
as a .pdf signature page were an original thereof.

 

    20

     

    

 

(i) Severability.
In the case any provision of this Agreement shall be invalid, illegal or unenforceable, such provision shall be replaced with a
valid, legal and enforceable provision that as closely as possible reflects the parties’ intent with respect thereto, and
the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

(j) Amendments.
Except as otherwise provided herein, the provisions of this Agreement may be amended at any time and from time to time, and particular
provisions of this Agreement may be waived, with and only with an agreement or consent in writing signed by the Company and the
Majority Holders; provided that this Agreement may not be amended and the observance of any term hereof may not be waived with
respect to any Holder without the written consent of such Holder if such amendment or waiver on its face materially and adversely
affects the rights of such Holder under this Agreement in a manner that is different than the other Holders. The Purchasers acknowledge
that by the operation of this Section 10(j), the Majority Holders may have the right and power to diminish or eliminate all rights
of the Purchasers under this Agreement.

 

(k) Independent
Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no
action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association,
a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert
or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters
and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such
claim, with respect to such obligations or transactions. Except as expressly provided herein, each Holder shall be entitled to
protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary
for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with
respect to the obligations of the Company contained herein was solely in the control of the Company, not the action or decision
of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by
any Holder. Except as expressly provided herein, it is expressly understood and agreed that each provision contained in this Agreement
is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among
Holders.

 

(l) Subsequent
Registration Rights. The Company shall not enter into any agreement granting registration rights more favorable than the registration
rights set forth in this Agreement without the written consent of the Majority Holders.

 

[COMPANY SIGNATURE PAGE FOLLOWS]

 

    21

     

    

 

This Registration
Rights Agreement is hereby executed as of the date first above written.

 

	 	THE COMPANY:
	 	 
	 	COMPASS THERAPEUTICS, INC.
	 	 
	 	By:	/s/
    Thomas Schuetz
	 	Name:	Thomas Schuetz
	 	Title:	CEO

 

	PURCHASERS	 	 
	 	 	 
	See Omnibus Signature Pages to Subscription Agreement	 	 
	 	 	 
	 	 	 
	REGISTRABLE PRE-MERGER 

STOCKHOLDER (INDIVIDUAL):	 	REGISTRABLE PRE-MERGER 

STOCKHOLDER (ENTITY):
	 	 	 
	
	 	

	Print Name	 	Print Name of Entity
	 	 	 	 
	
	 	By:	                                                            
	Signature	 	Name:  	 
	 	 	Title:	 
	 	 	 
	HOLDER OF MERGER SHARES (INDIVIDUAL):	 	HOLDER OF MERGER SHARES (ENTITY):
	 	 	 
	
	 	

	Print Name	 	Print Name of Entity
	 	 	 	 
	
	 	By:	                                           
	Signature	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	All Holders: Address	 	 	 
	 	 	 	 
	
	 	 	 
	
	 	 	 
	
	 	 	 
	 	 	 	 
	 	 	 	 

 

    22

     

    

 

Schedule 1

 

Holders of Merger Shares

 

	Name	 	Number of Shares
	 	 	 
	[**]	 	[**]
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

    23

     

    

 

Schedule 2

 

Registrable Pre-Merger Stockholders

 

	Name	 	Number of Shares
	 	 	 
	[**]	 	[**]
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

    24

     

    

 

Annex A

 

Compass Therapeutics, Inc. 

 

Selling Securityholder Notice and Questionnaire

 

The undersigned beneficial owner of Registrable
Securities of Compass Therapeutics, Inc., a Delaware corporation (the “Company”), understands that the
Company has filed or intends to file with the U.S. Securities and Exchange Commission a registration statement (the “Registration
Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended, of the Registrable
Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”)
to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the
address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration
Rights Agreement.

 

Certain legal consequences arise from being
named as a selling security holder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named
or not being named as a selling security holder in the Registration Statement and the related prospectus.

 

NOTICE

 

The undersigned beneficial owner (the “Selling
Securityholder”) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.

 

The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

1. Name:

 

	 	(a)	Full Legal Name of Selling Securityholder

 

	 
	 
	 
	 

 

	 	(b)	Full Legal Name of Registered Holder (holder of record) (if not the same as (a) above) through which Registrable Securities are held:

 

	 
	 
	 
	 

 

    25

     

    

 

	 	(c)	If you are not a natural person, full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):

 

	 
	 
	 
	 

 

2. Address for Notices to Selling Securityholder:

 

	 
	 
	 
	 

  

	Telephone:	 	 	Fax:	 
	 	 	 	 	 
	Email:	 	 	 	 

 

	Contact Person	 

 

3. Broker-Dealer Status:

 

	 	(a)	Are you a broker-dealer?

 

Yes ☐   No ☐

 

	 	(b)	If “yes” to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?

 

Yes ☐   No ☐

 

	 	Note: 	If “no” to Section 3(b), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	 	(c)	Are you an affiliate of a broker-dealer?

 

Yes ☐   No ☐

 

	 	(d)	If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

 

Yes ☐   No ☐

 

	 	Note: 	If “no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

    26

     

    

 

4. Beneficial Ownership of Securities
of the Company Owned by the Selling Securityholder:

 

Except as set forth below in
this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company.

 

	 	(a)	Please list the type (common stock, warrants, etc.) and amount of all securities of the Company (including any Registrable Securities) beneficially owned1 by the Selling Securityholder:

 

	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

5. Relationships with the Company:

 

Except as set forth below,
neither you nor (if you are a natural person) any member of your immediate family, nor (if you are not a natural person) any of
your affiliates2, officers, directors or principal equity holders (owners of 5% of more of the equity securities of
the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors
or affiliates) during the past three years.

 

State any exceptions here:

 

	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

 

	1 	Beneficially Owned: A “beneficial owner” of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise has or shares (i) voting power, including the power to direct the voting of such security, or (ii) investment power, including the power to dispose of, or direct the disposition of, such security. In addition, a person is deemed to have “beneficial ownership” of a security of which such person has the right to acquire beneficial ownership at any time within 60 days, including, but not limited to, any right to acquire such security: (i) through the exercise of any option, warrant or right, (ii) through the conversion of any security or (iii) pursuant to the power to revoke, or the automatic termination of, a trust, discretionary account or similar arrangement.

 

It is possible that a security
may have more than one “beneficial owner,” such as a trust, with two co-trustees sharing voting power, and
the settlor or another third party having investment power, in which case each of the three would be the “beneficial owner”
of the securities in the trust. The power to vote or direct the voting, or to invest or dispose of, or direct the investment or
disposition of, a security may be indirect and arise from legal, economic, contractual or other rights, and the determination of
beneficial ownership depends upon who ultimately possesses or shares the power to direct the voting or the disposition of the security.

 

The final determination of the
existence of beneficial ownership depends upon the facts of each case. You may, if you believe the facts warrant it, disclaim beneficial
ownership of securities that might otherwise be considered “beneficially owned” by you.

 

	2 	Affiliate: An “affiliate” is a company or person that directly, or indirectly through one or more intermediaries, controls you, or is controlled by you, or is under common control with you.

    27

     

    
 

The undersigned agrees
to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent
to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be
required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.

 

By signing below,
the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion
of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned
understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration
Statement and the related prospectus and any amendments or supplements thereto.

 

IN WITNESS WHEREOF the undersigned, by
authority duly given, has caused this Selling Securityholder Notice and Questionnaire to be executed and delivered either in person
or by its duly authorized agent. 

 

	BENEFICIAL OWNER (individual)	 	BENEFICIAL OWNER (entity)
	 	 	 
	              	 	                                   
	Signature	 	Name
of Entity
	 	 	 
	 	 	 
	Print Name	 	Signature
	 	 	 	 
	 	  	Print Name:	                           
	Signature (if Joint Tenants or Tenants in Common)	 	 	 
	 	 	Title:	 

 

PLEASE E-MAIL A COPY OF THE
COMPLETED AND EXECUTED SELLING SECURITYHOLDER NOTICE AND QUESTIONNAIRE TO:

 

Goodwin Procter LLP

100 Northern Avenue

Boston, MA 02210

Attention: [**]

Email: [**]

 

 

28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]